BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bansal N, Zelnick L, Bhat Z, Dobre M, He J, Lash J, Jaar B, Mehta R, Raj D, Rincon-Choles H, Saunders M, Schrauben S, Weir M, Wright J, Go AS; CRIC Study Investigators. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol 2019;73:2691-700. [PMID: 31146814 DOI: 10.1016/j.jacc.2019.02.071] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee H, Huang C, Yang C, Leu H, Huang P, Wu T, Lin S, Chen J. Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review. Clinical Cardiology 2022. [DOI: 10.1002/clc.23934] [Reference Citation Analysis]
2 Takeda T, Tsubaki A, Ikeda Y, Kato R, Hotta K, Inoue T, Kojima S, Kanai R, Terazaki Y, Uchida R, Makita S. The impacts of preoperative frailty on readmission after cardiac implantable electrical device implantation. PLoS One 2022;17:e0277115. [PMID: 36327285 DOI: 10.1371/journal.pone.0277115] [Reference Citation Analysis]
3 Rottmann FA, Breiden AK, Bemtgen X, Welte T, Supady A, Wengenmayer T, Staudacher DL. Levosimendan in acute heart failure with severely reduced kidney function, a propensity score matched registry study. Front Cardiovasc Med 2022;9:1027727. [DOI: 10.3389/fcvm.2022.1027727] [Reference Citation Analysis]
4 Shanah L, Mir T, Uddin MM, Hussain T, Parajuli T, Bhat Z. Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.10.161] [Reference Citation Analysis]
5 Uddin MM, Mir T, Briasoulis A, Akintoye E, Adegbala O, Shafi I, Qureshi WT, Afonso LC. Clinical Outcomes and 30-Day Readmissions Associated with High-Output Heart Failure. Hellenic Journal of Cardiology 2022. [DOI: 10.1016/j.hjc.2022.10.004] [Reference Citation Analysis]
6 Li L, Ma Z, Liu Y, Song W, Shen X, Fang S. Associations Between Serum Copper, Zinc and Copper/Zinc Ratio and Risk of Chronic Kidney Disease: A cross-sectional analysis of the NHANES 2011-2016.. [DOI: 10.21203/rs.3.rs-1952772/v1] [Reference Citation Analysis]
7 Yoshikoshi S, Yamamoto S, Suzuki Y, Imamura K, Harada M, Osada S, Kamiya K, Matsunaga A. Associations between dynapenia, cardiovascular hospitalizations, and all-cause mortality among patients on haemodialysis. J Cachexia Sarcopenia Muscle 2022. [PMID: 35916353 DOI: 10.1002/jcsm.13039] [Reference Citation Analysis]
8 Chaitman BR, Cyr DD, Alexander KP, Pracoń R, Bainey KR, Mathew A, Acharya A, Kunichoff DF, Fleg JL, Lopes RD, Sidhu MS, Anthopolos R, Rockhold FW, Stone GW, Maron DJ, Hochman JS, Bangalore S. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circ Cardiovasc Interv 2022;15:e012103. [PMID: 35973009 DOI: 10.1161/CIRCINTERVENTIONS.122.012103] [Reference Citation Analysis]
9 D’elia JA, Bayliss GP, Weinrauch LA. The Diabetic Cardiorenal Nexus. IJMS 2022;23:7351. [DOI: 10.3390/ijms23137351] [Reference Citation Analysis]
10 Chen J, Li Y, Liu P, Wu H, Su G. A nomogram to predict the in-hospital mortality of patients with congestive heart failure and chronic kidney disease. ESC Heart Fail 2022. [PMID: 35765720 DOI: 10.1002/ehf2.14042] [Reference Citation Analysis]
11 Fitzpatrick JK, Ambrosy AP, Parikh RV, Tan TC, Bansal N, Go AS; CRIC Study Investigators,. Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease. Am Heart J 2022;248:84-96. [PMID: 35278374 DOI: 10.1016/j.ahj.2022.02.001] [Reference Citation Analysis]
12 McCullough PA, Amin A, Pantalone KM, Ronco C. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials. J Am Heart Assoc 2022;:e024139. [PMID: 35616212 DOI: 10.1161/JAHA.121.024139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol 2022;21:47. [PMID: 35321742 DOI: 10.1186/s12933-022-01476-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Miura T, Sato T, Yano T, Takaguri A, Miki T, Tohse N, Nishizawa K. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms. Cardiovasc Drugs Ther 2022. [PMID: 35150385 DOI: 10.1007/s10557-022-07321-3] [Reference Citation Analysis]
15 Vassalotti JA, Boucree SC. Integrating Chronic Kidney Disease (CKD) into U.S. Primary Care: Bridging the knowledge and implementation gaps. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zelnick LR, Shlipak MG, Soliman EZ, Anderson A, Christenson R, Kansal M, Deo R, He J, Jaar BG, Weir MR, Rao P, Cohen DL, Cohen JB, Feldman HI, Go A, Bansal N, Appel LJ, Chen J, Cohen D, Feldman HI, Go AS, Lash JP, Nelson RG, Rahman M, Rao PS, Shah VO, Unruh ML. Prediction of incident heart failure in chronic kidney disease: the CRIC Study. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Padalia K, Hayek SS. Chronic Kidney Disease Is a Risk Enhancer for Cardiovascular Diseases. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-030-98824-1_14] [Reference Citation Analysis]
18 Yamaguchi R, Yamamoto M, Shimura T, Adachi Y, Kagase A, Tokuda T, Tsujimoto S, Koyama Y, Otsuka T, Yashima F, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Shirai S, Hayashida K, OCEAN-TAVI Investigators. Heart Failure Re-admission and Mortality in Chronic Kidney Disease Patients after Transcatheter AorticValve Replacement in Asian Population. Journal of Transcatheter Valve Therapies 2022;4:23-34. [DOI: 10.33290/jtvt.oa.22-0004] [Reference Citation Analysis]
19 Mehta R, Ning H, Bansal N, Cohen J, Srivastava A, Dobre M, Michos ED, Rahman M, Townsend R, Seliger S, Lash JP, Isakova T, Lloyd-Jones DM, Khan SS. Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Atherosclerosis. J Card Fail 2021:S1071-9164(21)00433-4. [PMID: 34763078 DOI: 10.1016/j.cardfail.2021.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Li W, Katamreddy A, Kataria R, Myerson ML, Taub CC. Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population. Drugs Real World Outcomes 2021. [PMID: 34478119 DOI: 10.1007/s40801-021-00277-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lu X, Li P, Teng C, Cai P, Jin L, Li C, Liu Q, Pan S, Dixon RAF, Wang B. Prognostic factors of Takotsubo cardiomyopathy: a systematic review. ESC Heart Fail 2021. [PMID: 34374223 DOI: 10.1002/ehf2.13531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
22 Bernacki GM, McDermott CL, Matlock DD, O'Hare AM, Brumback L, Bansal N, Kirkpatrick JN, Engelberg RA, Curtis JR. Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults with Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses. J Pain Symptom Manage 2021:S0885-3924(21)00483-8. [PMID: 34363954 DOI: 10.1016/j.jpainsymman.2021.07.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Faridi KF, Bhalla N, Atreja N, Venditto J, Khan ND, Wilson T, Fonseca E, Shen C, Yeh RW, Secemsky EA. New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims). Am J Cardiol 2021;151:70-7. [PMID: 34053629 DOI: 10.1016/j.amjcard.2021.04.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Srivastava A, Cai X, Mehta R, Lee J, Chu DI, Mills KT, Shafi T, Taliercio JJ, Hsu JY, Schrauben SJ, Saunders MR, Diamantidis CJ, Hsu CY, Waikar SS, Lash JP, Isakova T; CRIC Study Investigators. Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD. Kidney Int Rep 2021;6:1592-602. [PMID: 34169199 DOI: 10.1016/j.ekir.2021.03.883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wang YN, Wu XQ, Zhang DD, Hu HH, Liu JL, Vaziri ND, Guo Y, Zhao YY, Miao H. Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites. Front Pharmacol 2021;12:633566. [PMID: 33679418 DOI: 10.3389/fphar.2021.633566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
26 Lamprea-Montealegre JA, Shlipak MG, Estrella MM. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart 2021;107:1282-8. [PMID: 33568433 DOI: 10.1136/heartjnl-2020-318004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
27 Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW;  American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254-e743. [PMID: 33501848 DOI: 10.1161/cir.0000000000000950] [Cited by in Crossref: 1643] [Cited by in F6Publishing: 1803] [Article Influence: 1643.0] [Reference Citation Analysis]
28 Miyajima Y, Toyama T, Mori M, Nakade Y, Sato K, Yamamura Y, Ogura H, Yoneda-Nakagawa S, Oshima M, Miyagawa T, Usui S, Oe H, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Sakai Y, Furuichi K, Wada T. Relationships between kidney dysfunction and left ventricular diastolic dysfunction: a hospital-based retrospective study. J Nephrol 2021;34:773-80. [PMID: 33400138 DOI: 10.1007/s40620-020-00940-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Jawaid O, Gaddy A, Omar HR, Guglin M. Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes. Adv Chronic Kidney Dis 2021;28:37-46. [PMID: 34389136 DOI: 10.1053/j.ackd.2021.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Khaniukov OO, Smolianova OV. PREDICTORS OF RENAL FUNCTION DECLINE IN PATIENTS WITH CHRONIC HEART FAILURE ON THE BACKGROUND OF ARTERIAL HYPERTENSION. VPBM 2021;4:204. [DOI: 10.29254/2077-4214-2021-4-162-204-208] [Reference Citation Analysis]
31 Carrero JJ, Trevisan M, Evans M, Svennberg E, Szummer K. Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation. International Journal of Cardiology 2020;320:101-5. [DOI: 10.1016/j.ijcard.2020.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Fu EL, Uijl A, Dekker FW, Lund LH, Savarese G, Carrero JJ. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease. Circ: Heart Failure 2020;13. [DOI: 10.1161/circheartfailure.120.007180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Qiao Y, Shin JI, Chen TK, Sang Y, Coresh J, Vassalotti JA, Chang AR, Grams ME. Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade. Hypertension 2020;76:1762-8. [PMID: 32981368 DOI: 10.1161/HYPERTENSIONAHA.120.15956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Reddy YNV, Obokata M, Jones AD, Lewis GD, Shah SJ, Abouezzedine OF, Fudim M, Alhanti B, Stevenson LW, Redfield MM, Borlaug BA. Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction. J Card Fail 2020;26:919-28. [PMID: 32827644 DOI: 10.1016/j.cardfail.2020.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Li J, Albajrami O, Zhuo M, Hawley CE, Paik JM. Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease. Clin J Am Soc Nephrol 2020;15:1678-88. [PMID: 32518100 DOI: 10.2215/CJN.02690320] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
36 Epstein M, Epstein DL, Duprez D. Defining the Optimal Dialysis Regimen for Improving Left Ventricular Structure and Function: An Urgent Need. Journal of Cardiac Failure 2020;26:492-493. [DOI: 10.1016/j.cardfail.2020.05.004] [Reference Citation Analysis]
37 Gawor M, Puntmann VO. Aortic Stiffness and Heart Failure in Chronic Kidney Disease. Curr Cardiovasc Imaging Rep 2020;13. [DOI: 10.1007/s12410-020-9534-0] [Reference Citation Analysis]
38 Herzog CA. Congestive Heart Failure and Chronic Kidney Disease: The CardioRenal/NephroCardiology Connection. J Am Coll Cardiol 2019;73:2701-4. [PMID: 31146815 DOI: 10.1016/j.jacc.2019.03.474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Vidal-Petiot E, Greenlaw N, Kalra PR, Garcia-Moll X, Tardif JC, Ford I, Zamorano J, Ferrari R, Tendera M, Fox KM, Steg PG, On Behalf Of The Clarify Investigators. Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry. J Clin Med 2019;9:E4. [PMID: 31861379 DOI: 10.3390/jcm9010004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]